These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 318946)

  • 1. Identification of urinary metabolites of sodium dipropylacetate in man; potential sources of interference in organic acid screening procedures.
    Gompertz D; Tippett P; Bartlett K; Baillie T
    Clin Chim Acta; 1977 Jan; 74(2):153-60. PubMed ID: 318946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of branched medium chain length fatty acid. II--beta-oxidation of sodium dipropylacetate in rats.
    Matsumoto I; Kuhara T; Yoshino M
    Biomed Mass Spectrom; 1976 Oct; 3(5):235-40. PubMed ID: 788806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The metabolism of dipropylacetic acid dipropylacetamide. I. Identification and analysis in the urine by gas phase chromatography].
    Pfaff MC; Mahuzier G
    Ann Pharm Fr; 1975; 33(6-7):355-63. PubMed ID: 769646
    [No Abstract]   [Full Text] [Related]  

  • 4. Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid.
    Schmid RD
    Clin Chim Acta; 1977 Jan; 74(1):39-42. PubMed ID: 318945
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis.
    Acheampong A; Abbott F; Burton R
    Biomed Mass Spectrom; 1983 Nov; 10(11):586-95. PubMed ID: 6419788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of branched medium chain length fatty acid. I. Omega-oxidation of sodium dipropylacetate in rats.
    Kuhara T; Matsumoto I
    Biomed Mass Spectrom; 1974 Aug; 1(4):291-4. PubMed ID: 4441625
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of valproate sodium in rabbit, rat, dog, and man.
    Ferrandes B; Eymard P
    Epilepsia; 1977 Jun; 18(2):169-82. PubMed ID: 326545
    [No Abstract]   [Full Text] [Related]  

  • 8. The hydroxamate of valproic acid, a compound produced by oximation of urine from patients under valproic therapy.
    Libert R; Van Hoof F; Schanck A; Hoffmann E
    Biomed Environ Mass Spectrom; 1986 Nov; 13(11):599-603. PubMed ID: 2948586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and stereochemical determination of diunsaturated valproic acid analogs including its major diunsaturated metabolite.
    Acheampong A; Abbott FS
    J Lipid Res; 1985 Aug; 26(8):1002-8. PubMed ID: 3930642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of valproic acid and its metabolites by gas chromatography-mass spectrometry with selected ion monitoring.
    Tatsuhara T; Muro H; Matsuda Y; Imai Y
    J Chromatogr; 1987 Jul; 399():183-95. PubMed ID: 3116023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the urinary excretion of metabolites of valproic acid (dipropylacetic acid) in rats and humans (author's transl)].
    Kochen W; Imbeck H; Jakobs C
    Arzneimittelforschung; 1977; 27(5):1090-9. PubMed ID: 328021
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry.
    Fisher E; Wittfoht W; Nau H
    Biomed Chromatogr; 1992; 6(1):24-9. PubMed ID: 1600371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered metabolic profiles of valproic acid in a patient with Reye's syndrome.
    Kuhara T; Inoue Y; Matsumoto M; Shinka T; Matsumoto I; Kitamura K; Fujii H; Sakura N
    Clin Chim Acta; 1985 Jan; 145(2):135-42. PubMed ID: 3918813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2-Methyl-3-oxovaleric acid: a characteristic metabolite in propionic acidemia].
    Lehnert W; Junker A
    Clin Chim Acta; 1980 May; 104(1):47-51. PubMed ID: 7389125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperbaric oxygen: effect of sodium dipropylacetate and dipropylacetamine on convulsion seizures and pulmonary lesions in the mouse].
    Joanny P; Eymard P; Lacolle JY; Ferrandes B; Corriol J
    C R Seances Soc Biol Fil; 1975; 169(3):624-31. PubMed ID: 129210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of 3-keto-2-methylvaleric acid and 3-hydroxy-2-methylvaleric acid in a patient with propionic acidemia.
    Truscott RJ; Pullin CJ; Halpern B; Hammond J; Haan E; Danks DM
    Biomed Mass Spectrom; 1979 Jul; 6(7):294-300. PubMed ID: 486715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Lockard JS; Thummel KE; Baillie TA
    Drug Metab Dispos; 1986; 14(4):443-53. PubMed ID: 2873992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Ethylhydracrylic acid: a newly described urinary organic acid.
    Mamer OA; Tjoa SS
    Clin Chim Acta; 1974 Sep; 55(2):199-204. PubMed ID: 4458986
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.
    Levy RH; Rettenmeier AW; Anderson GD; Wilensky AJ; Friel PN; Baillie TA; Acheampong A; Tor J; Guyot M; Loiseau P
    Clin Pharmacol Ther; 1990 Sep; 48(3):225-35. PubMed ID: 2119269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.